Verzenio Extends Survival in Early Breast Cancer, Says Lilly’s Latest Study
Eli Lilly’s breast cancer drug Verzenio (abemaciclib) has achieved a significant milestone, with new study results showing it helps people with a common form of early-stage breast cancer live longer.…